Xiaowei Wu

8PUBLICATIONS
18CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.

Yabing Nan, Kunyu Wang, Menghan Hu

|Nov 24, 2025
IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer.

Yabing Nan, Sophie O'keefe, Xiadi He

|May 08, 2024
Targetable leukaemia dependency on noncanonical PI3Kγ signalling.

Qingyu Luo, Evangeline G Raulston, Miguel A Prado

|Dec 13, 2023
RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.

Xiao Yu, Pengfei Zhao, Qingyu Luo

|Jun 22, 2022
DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma.

Yabing Nan, Qingyu Luo, Xiaowei Wu

|Nov 11, 2021
USP12 promotes breast cancer angiogenesis by maintaining midkine stability.

Bin Sheng, Zichao Wei, Xiaowei Wu

Pageof 2

Frequent Collaborators

7 joint publications

Qingyu Luo

6 joint publications

Zhihua Liu

3 joint publications

Yabing Nan

2 joint publications

Xiao Yu